Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle

Rochelle R. Arvizo, Sounik Saha, Enfeng Wang, J. David Robertson, Resham Bhattacharya, Priyabrata Mukherjee

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Although biomedical applications of nanotechnology, which typically involve functionalized nanoparticles, have taken significant strides, biological characterization of unmodified nanoparticles remains underinvestigated. Herein we demonstrate that unmodified gold nanoparticles (AuNPs) inhibit the proliferation of cancer cells in a size-and concentration-dependent manner by abrogating MAPK-signaling. In addition, these AuNPs reverse epithelial-mes- enchymal transition (EMT) in cancer cells by reducing secretion of a number of proteins involved in EMT, up-regulating E-Cadherin, and down-regulating Snail, N-Cadherin, and Vimentin. Inhibition of MAPK signaling and reversal of EMT upon AuNP treatment inhibits tumor growth and metastasis in two separate orthotopic models of ovarian cancer. Western blot analyses of tumor tissues reveal up-regulation of E-Cadherin and down-regulation of Snail and phospho-MAPK, confirming the reversal of EMT and inhibition of MAPK signaling upon AuNP treatment. The ability of a single self-therapeutic nanoparticle to abrogate signaling cascades of multiple growth factors is distinctive and purports possible medical applications as potential antitumor and antimetastatic agent.

Original languageEnglish (US)
Pages (from-to)6700-6705
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number17
DOIs
StatePublished - Apr 23 2013

Fingerprint

Nanoparticles
Cadherins
Neoplasm Metastasis
Growth
Neoplasms
Nanotechnology
Epithelial-Mesenchymal Transition
Vimentin
Therapeutics
Gold
Antineoplastic Agents
Ovarian Neoplasms
Intercellular Signaling Peptides and Proteins
Up-Regulation
Down-Regulation
Western Blotting
Cell Proliferation
Proteins

Keywords

  • Drug delivery
  • Heparin-binding growth factors

ASJC Scopus subject areas

  • General

Cite this

Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. / Arvizo, Rochelle R.; Saha, Sounik; Wang, Enfeng; Robertson, J. David; Bhattacharya, Resham; Mukherjee, Priyabrata.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, No. 17, 23.04.2013, p. 6700-6705.

Research output: Contribution to journalArticle

Arvizo, Rochelle R. ; Saha, Sounik ; Wang, Enfeng ; Robertson, J. David ; Bhattacharya, Resham ; Mukherjee, Priyabrata. / Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. In: Proceedings of the National Academy of Sciences of the United States of America. 2013 ; Vol. 110, No. 17. pp. 6700-6705.
@article{e762f345ef794550ada67149eb24affa,
title = "Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle",
abstract = "Although biomedical applications of nanotechnology, which typically involve functionalized nanoparticles, have taken significant strides, biological characterization of unmodified nanoparticles remains underinvestigated. Herein we demonstrate that unmodified gold nanoparticles (AuNPs) inhibit the proliferation of cancer cells in a size-and concentration-dependent manner by abrogating MAPK-signaling. In addition, these AuNPs reverse epithelial-mes- enchymal transition (EMT) in cancer cells by reducing secretion of a number of proteins involved in EMT, up-regulating E-Cadherin, and down-regulating Snail, N-Cadherin, and Vimentin. Inhibition of MAPK signaling and reversal of EMT upon AuNP treatment inhibits tumor growth and metastasis in two separate orthotopic models of ovarian cancer. Western blot analyses of tumor tissues reveal up-regulation of E-Cadherin and down-regulation of Snail and phospho-MAPK, confirming the reversal of EMT and inhibition of MAPK signaling upon AuNP treatment. The ability of a single self-therapeutic nanoparticle to abrogate signaling cascades of multiple growth factors is distinctive and purports possible medical applications as potential antitumor and antimetastatic agent.",
keywords = "Drug delivery, Heparin-binding growth factors",
author = "Arvizo, {Rochelle R.} and Sounik Saha and Enfeng Wang and Robertson, {J. David} and Resham Bhattacharya and Priyabrata Mukherjee",
year = "2013",
month = "4",
day = "23",
doi = "10.1073/pnas.1214547110",
language = "English (US)",
volume = "110",
pages = "6700--6705",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "17",

}

TY - JOUR

T1 - Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle

AU - Arvizo, Rochelle R.

AU - Saha, Sounik

AU - Wang, Enfeng

AU - Robertson, J. David

AU - Bhattacharya, Resham

AU - Mukherjee, Priyabrata

PY - 2013/4/23

Y1 - 2013/4/23

N2 - Although biomedical applications of nanotechnology, which typically involve functionalized nanoparticles, have taken significant strides, biological characterization of unmodified nanoparticles remains underinvestigated. Herein we demonstrate that unmodified gold nanoparticles (AuNPs) inhibit the proliferation of cancer cells in a size-and concentration-dependent manner by abrogating MAPK-signaling. In addition, these AuNPs reverse epithelial-mes- enchymal transition (EMT) in cancer cells by reducing secretion of a number of proteins involved in EMT, up-regulating E-Cadherin, and down-regulating Snail, N-Cadherin, and Vimentin. Inhibition of MAPK signaling and reversal of EMT upon AuNP treatment inhibits tumor growth and metastasis in two separate orthotopic models of ovarian cancer. Western blot analyses of tumor tissues reveal up-regulation of E-Cadherin and down-regulation of Snail and phospho-MAPK, confirming the reversal of EMT and inhibition of MAPK signaling upon AuNP treatment. The ability of a single self-therapeutic nanoparticle to abrogate signaling cascades of multiple growth factors is distinctive and purports possible medical applications as potential antitumor and antimetastatic agent.

AB - Although biomedical applications of nanotechnology, which typically involve functionalized nanoparticles, have taken significant strides, biological characterization of unmodified nanoparticles remains underinvestigated. Herein we demonstrate that unmodified gold nanoparticles (AuNPs) inhibit the proliferation of cancer cells in a size-and concentration-dependent manner by abrogating MAPK-signaling. In addition, these AuNPs reverse epithelial-mes- enchymal transition (EMT) in cancer cells by reducing secretion of a number of proteins involved in EMT, up-regulating E-Cadherin, and down-regulating Snail, N-Cadherin, and Vimentin. Inhibition of MAPK signaling and reversal of EMT upon AuNP treatment inhibits tumor growth and metastasis in two separate orthotopic models of ovarian cancer. Western blot analyses of tumor tissues reveal up-regulation of E-Cadherin and down-regulation of Snail and phospho-MAPK, confirming the reversal of EMT and inhibition of MAPK signaling upon AuNP treatment. The ability of a single self-therapeutic nanoparticle to abrogate signaling cascades of multiple growth factors is distinctive and purports possible medical applications as potential antitumor and antimetastatic agent.

KW - Drug delivery

KW - Heparin-binding growth factors

UR - http://www.scopus.com/inward/record.url?scp=84876871170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876871170&partnerID=8YFLogxK

U2 - 10.1073/pnas.1214547110

DO - 10.1073/pnas.1214547110

M3 - Article

C2 - 23569259

AN - SCOPUS:84876871170

VL - 110

SP - 6700

EP - 6705

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 17

ER -